Navigation Links
Syngenta holds Annual General Meeting

BASEL, Switzerland, April 21 /PRNewswire-FirstCall/ -- At the Annual General Meeting of Syngenta AG on 21 April 2009, the shareholders approved all the motions proposed by the Board of Directors.

Shareholders approved a dividend of CHF 6.00 per share for the business year 2008, an increase of 25% over the previous year. Shareholders also approved a reduction of the share capital to CHF 9,459,984.90 through the cancellation of 2,315,008 shares, which the Company repurchased in 2008 within the scope of the approved repurchase program.

Rupert Gasser and Peter Doyle stepped down from the Board, having reached the statutory maximum age of 70. Syngenta Chairman Martin Taylor said: "On behalf of the Board, I would like to thank both for their outstanding contribution to the Company. Their considerable experience and sound guidance have been instrumental in our collective success."

Stefan Borgas, CEO of Lonza, and David Lawrence, former Head of R&D at Syngenta, were elected as new members of the Board of Directors.

Peggy Bruzelius, Pierre Landolt and Jurg Witmer were re-elected to the Board. Following a recent decision of the Board of Directors, Jurg Witmer takes the role of Vice Chairman of the Board of Directors with immediate effect.

Syngenta is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to

Note to the editor:

The speech of the Chairman, the presentation of the CEO and images of the Annual General Meeting and the newly elected Board members can be found at

    Syngenta International AG

    Media Office
    CH-4002 Basel
    Tel:   +41 61 323 23 23
    Fax:   +41 61 323 24 24

    Media contact:
    Medard Schoenmaeckers
    Switzerland   +41 61 323 2323

    Analyst/Investor contacts:
    Jennifer Gough
    Switzerland   +41 61 323 5059
    USA           +1 202 737 6521

    John Hudson
    Switzerland   +41 61 323 6793
    USA           +1 202 737 6520

SOURCE Syngenta
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta Licenses Chromatin Gene Stacking Technology
2. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
3. Syngenta To Build Major Global Biotech Research Center in Beijing, China
4. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
5. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
6. Syngenta Enters Into Research Collaboration With Anhui Academy, China
7. Syngenta Board Proposes Stefan Borgas to Become New Director
8. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
9. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
10. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
11. So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, will present at ... week in New York City . The ... December 1, 2015 at 9:30 a.m. EST. ... the website at least 15 minutes prior to the presentation ...
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... 23, 2015 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its preliminary unaudited financial results for the second quarter ... 30, 2015. --> --> ... Revenues for the second quarter of fiscal 2016 increased ...
(Date:11/23/2015)... The royalty-free a greement a ... for 112 low- and m iddle-i ... --> The Medicines Patent Pool (MPP) today announced ... agreement with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral ... HCV virus.  The royalty-free licence will enable generic manufacture of ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):